These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 33825916
1. Motion-compensated FDG PET/CT for oesophageal cancer. Voncken FEM, Vegt E, van Sandick JW, van Dieren JM, Grootscholten C, Bartels-Rutten A, Takken SL, Sonke JJ, van de Kamer JB, Aleman BMP. Strahlenther Onkol; 2021 Sep; 197(9):791-801. PubMed ID: 33825916 [Abstract] [Full Text] [Related]
3. Cervical ultrasonography has no additional value over negative 18F-FDG PET/CT scans for diagnosing cervical lymph node metastases in patients with oesophageal cancer. Goense L, Meziani J, van Rossum PSN, Wessels FJ, Lam MGEH, van Hillegersberg R, Ruurda JP. Eur Radiol; 2018 May; 28(5):2031-2037. PubMed ID: 29218619 [Abstract] [Full Text] [Related]
4. Using 18F-fluorodeoxyglucose positron emission tomography/computed tomography to estimate the length of gross tumor and involvement of lymph nodes in esophagogastric junction carcinoma. Ma CL, Li XD, Sun XR, Zhao DB, Yuan YP, Yu YH. J Cancer Res Ther; 2018 May; 14(4):896-901. PubMed ID: 29970673 [Abstract] [Full Text] [Related]
5. Dual-time point 18F-FDG PET/CT for the staging of oesophageal cancer: the best diagnostic performance by retention index for N-staging in non-calcified lymph nodes. Park S, Paeng JC, Kang CH, Cheon GJ, Kang KW, Chung JK, Lee DS. Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1317-1328. PubMed ID: 29502309 [Abstract] [Full Text] [Related]
6. Comparative accuracy of qualitative and quantitative 18F-FDG PET/CT analysis in detection of lymph node metastasis from anal cancer. Chulroek T, Kordbacheh H, Wangcharoenrung D, Cattapan K, Heidari P, Harisinghani MG. Abdom Radiol (NY); 2019 Mar; 44(3):828-835. PubMed ID: 30694369 [Abstract] [Full Text] [Related]
7. Lymph node standardized uptake values at pre-treatment 18F-fluorodeoxyglucose positron emission tomography as a valuable prognostic factor for distant metastasis in nasopharyngeal carcinoma. Jeong Y, Baek S, Park JW, Joo JH, Kim JS, Lee SW. Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776 [Abstract] [Full Text] [Related]
8. Factors affecting the accuracy of 18F-FDG PET/CT in evaluating axillary metastases in invasive breast cancer. Kutluturk K, Simsek A, Comak A, Gonultas F, Unal B, Kekilli E. Niger J Clin Pract; 2019 Jan; 22(1):63-68. PubMed ID: 30666022 [Abstract] [Full Text] [Related]
9. Prediction of Lymph Node Maximum Standardized Uptake Value in Patients With Cancer Using a 3D Convolutional Neural Network: A Proof-of-Concept Study. Shaish H, Mutasa S, Makkar J, Chang P, Schwartz L, Ahmed F. AJR Am J Roentgenol; 2019 Feb; 212(2):238-244. PubMed ID: 30540209 [Abstract] [Full Text] [Related]
10. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study. Han D, Yu J, Zhong X, Fu Z, Mu D, Zhang B, Xu G, Yang W, Zhao S. Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837 [Abstract] [Full Text] [Related]
11. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients. Herbrik M, Treffert J, Geiger B, Riegger C, Hartung V, Rosenbaum-Krumme SJ, Forsting M, Antoch G, Heusner TA. J Nucl Med; 2011 Oct; 52(10):1520-5. PubMed ID: 21908390 [Abstract] [Full Text] [Related]
13. PET/CT in breast cancer staging is useful for evaluation of axillary lymph node and distant metastases. Davidson T, Shehade N, Nissan E, Sklair-Levy M, Ben-Haim S, Barshack I, Zippel D, Halevy A, Chikman B. Surg Oncol; 2021 Sep; 38():101567. PubMed ID: 33866190 [Abstract] [Full Text] [Related]
15. Diagnostic Value of 18F-fluorodeoxyglucose Positron Emission Tomography with Computed Tomography for Lymph Node Staging in Patients with Upper Tract Urothelial Carcinoma. Voskuilen CS, Schweitzer D, Jensen JB, Nielsen AM, Joniau S, Muilwijk T, Necchi A, Azizi M, Spiess PE, Briganti A, Bandini M, Goffin K, Bouchelouche K, van Werkhoven E, Shariat SF, Xylinas E, Azawi NH, Ku JH, Foerster B, van Rhijn BWG, Vegt E, Hendricksen K. Eur Urol Oncol; 2020 Feb; 3(1):73-79. PubMed ID: 31591037 [Abstract] [Full Text] [Related]